Effects of ramosetron orally disintegrating tablets on the prophylaxis of post-discharge nausea and/or vomiting in female patients undergoing day surgery under general anesthesia: a randomized controlled trial
Abstract Background This study was performed to evaluate the effectiveness of ramosetron orally disintegrating tablets (ODTs) in preventing post-discharge nausea and/or vomiting (PDNV) in female patients following outpatient surgery under general anesthesia. Methods This multicenter randomized study...
Main Authors: | Hyun-Jung Shin, Yong-Hee Park, Minying Chang, Yun Jeong Chae, Hun-Taek Lee, Oh Haeng Lee, Sang-Kee Min, Sang-Hwan Do |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Perioperative Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13741-022-00251-6 |
Similar Items
-
Efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery
by: So-Young Yang, et al.
Published: (2012-03-01) -
The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
by: Dong Chul Lee, et al.
Published: (2011-08-01) -
Scheduled injection of ramosetron for prevention of nausea and vomiting following single-port access total laparoscopic hysterectomy: a prospective randomized study
by: Shoou-Chern Li, et al.
Published: (2019-09-01) -
Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration
by: Xia J, et al.
Published: (2020-03-01) -
Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
by: Yong Seon Choi, et al.
Published: (2012-06-01)